Assertio Therapeutics Inc (ASRT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Sales | 128,404 | 94,407 | 95,413 | 100,457 | 90,447 |
| Cost of Goods | 12,044 | 17,703 | 17,396 | 19,725 | 17,774 |
| Gross Profit | 116,360 | 76,704 | 78,017 | 80,732 | 72,673 |
| Operating Expenses | 65,066 | 110,092 | 77,175 | 85,525 | 80,112 |
| Operating Income | 51,338 | -32,685 | 1,238 | -4,068 | -6,665 |
| Interest Expense | 18,068 | 17,855 | 17,815 | 17,758 | 20,124 |
| Other Income | 229 | 16,567 | 72 | -5,082 | 250 |
| Pre-tax Income | 33,499 | -33,973 | -16,505 | -26,908 | -26,539 |
| Income Tax | -325 | -869 | -513 | -249 | 202 |
| Net Income Continuous | 33,824 | -33,104 | -15,992 | -26,659 | -26,741 |
| Net Income | $33,824 | $-33,104 | $-15,992 | $-26,659 | $-26,741 |
| EPS Basic Total Ops | 2.12 | -2.08 | -1.00 | -1.72 | -1.72 |
| EPS Basic Continuous Ops | 2.13 | -2.10 | -1.02 | -1.71 | -1.72 |
| EPS Diluted Total Ops | 1.92 | -2.08 | -1.00 | -1.72 | -1.72 |
| EPS Diluted Continuous Ops | 1.65 | -2.10 | -1.02 | -1.71 | -1.72 |
| EBITDA(a) | $83,674 | $-1,048 | $32,416 | $27,035 | $24,334 |